Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | MAHAVIR PHARMACEUTICALS | Awarded | 1 | ₹75,000 |
| 2 | Schedule 2 | PRATHMESH DISTRIBUTOR | Awarded | 1 | ₹10,202.40 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
10 Sept 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
LEDIPASVIR 90MG+ SOFOSBUVIR 400MG TAB
LEFLUNOMIDE 10 MG TAB
8272883
GEM/2025/B/6614751
Two Packet Bid
LEDIPASVIR 90MG+ SOFOSBUVIR 400MG TAB
15 days
Central Delhi
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
10%
Exempted
10 Sept 2025
27 Aug 2025
10 Sept 2025
LEDIPASVIR 90MG+ SOFOSBUVIR 400MG TAB
LEFLUNOMIDE 10 MG TAB
LEFLUNOMIDE 10 MG TAB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8272883.pdf
GEM_BID
specification_re_107_2025-08-25-16-14-41_1f82b8b4970682d958d8827c76d3dd64.pdf
SPECIFICATION
specification_re_107_2025-08-25-16-15-48_cfae8bba35a9778883198d78ea216cbf.pdf
SPECIFICATION
newatc_d5315e60-1709-4ffa-8bc11756270391783_tejasvagupta.865n@gov.in.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .